|

Liver Cancer Clinical Trials in San Francisco, CA

32 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT TrialPhase 3<1 mi
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway AberrationsPhase 1<1 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—<1 mi
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or LymphomaPhase 3<1 mi
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPhase 1/2<1 mi
National Liver Cancer Screening TrialPhase 4<1 mi
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorPhase 1/2<1 mi
A Multicenter Cancer Biospecimen Collection Study—<1 mi
Checkpoint Inhibition In Pediatric Hepatocellular CarcinomaPhase 2<1 mi
HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant RecipientsN/A<1 mi
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer—<1 mi
Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersN/A<1 mi
HEalth Advocate for Liver Transplant - PilotN/A<1 mi
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular CarcinomaPhase 2<1 mi
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular CarcinomaPhase 1/2<1 mi
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)Phase 1/2<1 mi
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsPhase 28 mi
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)—8 mi
Observational Study Protocol: LIVER-R—21 mi
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients—28 mi
Dose-defining Study of Tirapazamine Combined With Embolization in Liver CancerPhase 1/228 mi
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaPhase 328 mi
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIN/A28 mi
REGULUS: MRI-guided Adaptive SABR for Liver CancersPhase 228 mi
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology—28 mi
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsPhase 1/228 mi
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid TumorsPhase 128 mi
Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90—28 mi
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 CirrhosisPhase 228 mi
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesPhase 128 mi
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma—28 mi
The Vanguard Study: Testing a New Way to Screen for CancerN/A31 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.